脓毒症早期目标导向治疗:临床试验生存结局差异的新解释
该研究采用随机效应和贝叶斯分层分析,纳入31项观察性研究(n=15,656)和6项随机研究(n=4,342),共19,998例严重脓毒症和/或脓毒性休克患者。总体分析显示早期目标导向治疗与死亡风险降低23%相关(RR=0.77,95%CI 0.71-0.83;P<0.0001),但该获益仅见于观察性研究(RR=0.73,95%CI 0.67-0.80;P<0.0001),随机研究未见显著获益(RR=0.92,95%CI 0.78-1.07;P=0.268)。Meta回归显示,唯一能解释随机与观察性研究病死率差异的因素是首次抗生素时间和6小时、4小时、3小时内抗生素使用及恰当抗生素使用。早期目标导向治疗在高疾病严重度患者中与病死率增加相关。
要点
- 总体19,998例脓毒症患者中,早期目标导向治疗与死亡风险降低23%相关(RR=0.77,95%CI 0.71-0.83;P<0.0001)。
- 观察性研究显示早期目标导向治疗降低死亡风险(RR=0.73,95%CI 0.67-0.80;P<0.0001),随机研究未见显著获益(RR=0.92,95%CI 0.78-1.07;P=0.268)。
- 唯一能解释随机与观察性研究病死率差异的因素是首次抗生素时间(R=87%)、6小时内(R=94%)、4小时内(R=99%)、3小时内(R=99%)及恰当抗生素使用(R=96%)。
- 早期目标导向治疗在高疾病严重度患者中与病死率增加相关。
- 早期目标导向治疗集束化依从性和血流动力学目标达成情况与生存差异无关。
适用人群与场景
- 严重脓毒症和/或脓毒性休克患者,共19,998例(观察性研究15,656例,随机研究4,342例)。
研究设计与关键结果
- 研究设计为随机效应和贝叶斯分层分析,纳入31项观察性研究(n=15,656)和6项随机研究(n=4,342),共19,998例患者。
- 总体分析:早期目标导向治疗与死亡风险降低23%相关(RR=0.77,95%CI 0.71-0.83;P<0.0001)。
- 观察性研究:早期目标导向治疗与死亡风险降低相关(RR=0.73,95%CI 0.67-0.80;P<0.0001);随机研究:未见显著获益(RR=0.92,95%CI 0.78-1.07;P=0.268)。
- Meta回归分析显示观察性研究较随机研究死亡风险更低(RR=0.81,95%CI 0.68-0.95;P=0.01)。
- 与病死率差异相关的因素包括:急性生理与慢性健康评分Ⅱ(RR=1.05,95%CI 1.02-1.09;P=0.003)、序贯器官衰竭评估(RR=1.09,95%CI 1.00-1.18;P=0.04)、休克存在(RR=1.007,95%CI 1.002-1.013;P=0.006)、首次抗生素时间(RR=1.22,95%CI 1.09-1.36;P=0.0006)、6小时内使用抗生素(RR=0.20,95%CI 0.09-0.45;P=0.0001)、4小时内(RR=0.16,95%CI 0.06-0.39;P=0.0001)、3小时内(RR=0.09,95%CI 0.03-0.27;P<0.0001)。
- 唯一能解释随机与观察性研究病死率差异的因素是首次抗生素时间(R=87%)、6小时内抗生素使用(R=94%)、4小时内(R=99%)、3小时内(R=99%)及恰当抗生素使用(R=96%)。
- 年龄、国家、医院位置、年代、收缩压、平均动脉压、乳酸、集束化依从性、输液量及血流动力学目标达成情况与生存差异无关。
- 早期目标导向治疗在高疾病严重度患者中与病死率增加相关。
证据类型、等级与局限
- 证据类型:随机效应和贝叶斯分层分析(系统评价与Meta分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 早期目标导向治疗集束化依从性和血流动力学目标达成情况与生存差异无关,提示临床不应仅关注集束化依从性。
- 观察性研究中早期目标导向治疗组的生存获益可能与更快、更恰当地使用抗生素有关,随机试验中未见此获益。
- 早期目标导向治疗在高疾病严重度患者中与病死率增加相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Early goal-directed therapy has shown discordant survival outcomes in sepsis studies. We aim to find the reasons for this discordance.
DESIGN: Random-effects and Bayesian hierarchical analyses.
SETTING: Studies that evaluated early goal-directed therapy.
SUBJECTS: Patients with severe sepsis and/or septic shock.
INTERVENTIONS: Early goal-directed therapy.
MEASUREMENTS AND MAIN RESULTS: A total of 19,998 patients were included in the main analysis: 31 observational (n = 15,656) and six randomized (n = 4,342) studies. The analysis from 37 studies showed that early goal-directed therapy was associated with a 23% reduction in the risk of death: relative risk = 0.77 (95% CI, 0.71-0.83); p value of less than 0.0001. Mortality reduction was seen with observational studies: relative risk = 0.73 (0.67-0.80); p value of less than 0.0001 but not with randomized studies: relative risk = 0.92 (0.78-1.07); p = 0.268. Meta-regression analysis showed lower risk of death in observational compared with randomized studies: relative risk = 0.81 (0.68-0.95); p = 0.01. Differences in age, country, hospital location, era, systolic pressure, mean arterial pressure, lactate, bundle compliance, amount of fluid administered, and hemodynamic goal achievements were not associated with survival differences between studies. Factors associated with mortality differences between early goal-directed therapy and control included Acute Physiology and Chronic Health Evaluation II (relative risk = 1.05 [1.02-1.09]; p = 0.003), Sequential Organ Failure Assessment (relative risk = 1.09 [1.00-1.18]; p = 0.04), presence of shock (relative risk = 1.007 [1.002-1.013]; p = 0.006), time-to-first antibiotic (relative risk = 1.22 [1.09-1.36]; p = 0.0006), antibiotic administration within 6 hours (relative risk = 0.20 [0.09-0.45]; p = 0.0001), 4 hours (relative risk = 0.16 [0.06-0.39]; p = 0.0001), and 3 hours (relative risk = 0.09 [0.03-0.27]; p < 0.0001). The only factors that explained mortality differences between randomized and observational studies were time-to-first antibiotic (R = 87%), antibiotic administration within 6 hours (R = 94%), 4 hours (R = 99%), 3 hours (R = 99%), and appropriate antibiotic use (R = 96%).
CONCLUSIONS: Survival discordance was not associated with differences in early goal-directed therapy bundle compliance or hemodynamic goal achievement. Our results suggest that it was associated with faster and more appropriate antibiotic co-intervention in the early goal-directed therapy arm compared with controls in the observational studies but not in the randomized trials. Early goal-directed therapy was associated with increased mortality in patients with high-disease severity.
参考来源
- Kalil AC, Johnson DW, Lisco SJ, et al. Early Goal-Directed Therapy for Sepsis: A Novel Solution for Discordant Survival Outcomes in Clinical Trials. Crit Care Med. 2017. PMID: 28067711. doi:10.1097/CCM.0000000000002235
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。